A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CF147F30.svg?ark=w1%2F20260515%2FCF147F30)](https://nobleid.org/work/w1/20260515/CF147F30)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors